Preparation and evaluation of a lipid-based drug delivery system to ımprove valsartan oral bioavailability: pharmacokinetic and pharmacodynamic analysis

References

• Bhagani S, Kapil V, Lobo MD. Hypertension. Medicine. 2018;46(9):509–515.
   Google Scholar
• O'Shea PM, Griffin TP, Fitzgibbon M. Hypertension: the role of biochemistry in the diagnosis and management. Clin Chim Acta. 2017;465:131–143.
   PubMed Web of Science ®Google Scholar
• Wu C, Hu Y, Li Q, et al. Synthesis, pharmacokinetics, and pharmacodynamics studies of valsartan peptide derivatives. Arch Pharm (Weinheim). 2012;345(5):393–400.
   PubMed Web of Science ®Google Scholar
• Saydam M, Takka S. Bioavailability file: valsartan. FABAD J Pharm Sci. 2007;32:185–196.
   Google Scholar
• Siddiqui N, Husain A, Chaudhry L, et al. Pharmacological and pharmaceutical profile of valsartan: a review. J Appl Pharm Sci. 2011;1:12–19.
   Google Scholar
• Hamed R. Physiological parameters of the gastrointestinal fluid impact the dissolution behavior of the BCS class IIa drug valsartan. Pharm Dev Technol. 2018;23(10):1168–1176.
   PubMed Web of Science ®Google Scholar
• Hamed R, Hasan Alnadi S. Transfer behavior of the weakly acidic BCS class II drug valsartan from the stomach to the small ıntestine during fasted and fed states. AAPS PharmSciTech. 2018;19:2213–2225.
   PubMed Web of Science ®Google Scholar
• Kallakunta VR, Bandari S, Jukanti R, et al. Oral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluation. Powder Technology. 2012;221:375–382.
   Web of Science ®Google Scholar
• Palmer AM. New horizons in drug metabolism, pharmacokinetics and drug discovery. Drug News Perspect. 2003;16(1):57–62.
   PubMedGoogle Scholar
• Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems – an overview. Acta Pharmaceutica Sinica B. 2013;3(6):361–372.
   Web of Science ®Google Scholar
• Savla R, Browne J, Plassat V, et al. Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm. 2017;43(11):1743–1758.
   PubMed Web of Science ®Google Scholar
• Imam SS, Ahad A, Aqil M, et al. A validated RP-HPLC method for simultaneous determination of propranolol and valsartan in bulk drug and gel formulation. J Pharm Bioallied Sci. 2013;5(1):61–65.
   PubMedGoogle Scholar
• Nagakanyaka Devi P, Rao GD, Satyanarayana B. Development and validation of RP-HPLC method for quantification of valsartan and its pharmaceutical formulations. Int J Drug Develop Res. 2013;5:199–205.
   Google Scholar
• Zarghi A, Shafaati A, Foroutan SM, et al. Rapid quantification of valsartan in human plasma by liquid chromatography using a monolithic column and a fluorescence detection: application for pharmacokinetic studies. Sci Pharm. 2008;76(3):439–450.
   Google Scholar
• European Medicines Agency. Guideline on bioanalytical method validation; 2011. www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf
   Google Scholar
• Ege MA, Karasulu HY, Güneri T. Triangle phase diagram analysis software. Paper presented at: The 4th International Postgraduate Research Symposium on Pharmaceutics; 2004 Sept 20–22; Istanbul.
   Google Scholar
• Beg S, Swain S, Singh HP, et al. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech. 2012;13(4):1416–1427.
   PubMed Web of Science ®Google Scholar
• Beg S, Katare OP, Saini S, et al. Solid self-nanoemulsifying systems of olmesartan medoxomil: formulation development, micromeritic characterization, in vitro and in vivo evaluation. Powder Technol. 2016;294:93–104.
   Web of Science ®Google Scholar
• Mahajan P, Mahajan SC, Mishra DK. Valsartan release from sustained release matrix tablet and effect of cellulose derivatives. Int J Pharm Life Sci. 2011;2:521–530.
   Google Scholar
• Zhang J, Lv Y, Zhao S, et al. Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location. AAPS PharmSciTech. 2014;15(3):731–740.
   PubMed Web of Science ®Google Scholar
• Parhizkar E, Emadi L, Alipour S. Development and evaluation of midazolam in situ nasal gel properties in presence of solubility enhancers at cilia-friendly pH. Macromol. Res. 2017;25(3):255–261.
   Web of Science ®Google Scholar
• Diril M, Türkyılmaz GY, Karasulu HY. Formulation and ın vitro evaluation of self microemulsifying drug delivery system containing atorvastatin calcium. Curr Drug Deliv. 2019;16(8):768–779.
   PubMed Web of Science ®Google Scholar
• Balata GF, Essa EA, Shamardl HA, et al. Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol. Drug Des Devel Ther. 2016;10:117–128.
   PubMed Web of Science ®Google Scholar
• Ammar HO, El-Feky GS, Ali AMA, et al. Enhancement of oral bioavailability of repaglinide by self-nanoemulsifying drug delivery system. Int J Pharm Pharm Sci. 2014;6:603–606.
   Google Scholar
• Rani S, Rana R, Saraogi GK, et al. Self-emulsifying oral lipid drug delivery systems: advances and challenges. AAPS PharmSciTech. 2019;20(3):129.
   PubMed Web of Science ®Google Scholar
• Mishra V, Nayak P, Yadav N, et al. Orally administered self-emulsifying drug delivery system in disease management: advancement and patents. Expert Opin Drug Deliv. 2021;18(3):315–332.
   PubMed Web of Science ®Google Scholar
• Patel N, Baldaniya M, Raval M, et al. Formulation and development of In situ nasal gelling systems for quetiapine fumarate-loaded mucoadhesive microemulsion. J Pharm Innov. 2015;10(4):357–373.
   Web of Science ®Google Scholar
• Eid AMM, Saringat HB, Arafat OM. The effect of surfactant blends on the production of Self-Emulsifying system novel nano-emulsifying system for biologically active essential oils view project haruan for wound healing view project. Int J Pharm Front Res. 2012;2:21–31.
   Google Scholar
• Wang L, Yan W, Tian Y, et al. Self-microemulsifying drug delivery system of phillygenin: formulation development, characterization and pharmacokinetic evaluation. Pharmaceutics. 2020;12(2):117–130.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Marques S, Sarmento B. Measuring the emulsification dynamics and stability of self-emulsifying drug delivery systems. Eur J Pharm Biopharm. 2018;123:1–8.
   PubMed Web of Science ®Google Scholar
• Bakhle SS, Avari JG. Development and evaluation of liquid and solid self-microemulsifying drug delivery system of lovastatin. Asian J Pharm. 2016;10:22–35.
   Google Scholar
• Amrutkar C, Salunkhe K, Chaudhari S. Study on self nano emulsifying drug delivery system of poorly water soluble drug rosuvastatin calcium. World J Pharm Res. 2014;3:1251–2137.
   Google Scholar
• Balakumar K, Raghavan CV, Selvan NT, et al. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surf B Biointerfaces. 2013;112:337–343.
   PubMed Web of Science ®Google Scholar
• Shukla JB, Patel SJ. Formulation and evaluation of self micro emulsifying system of candesartan cilexetil. Int J Pharm Pharm Sci. 2010;2:143–146.
   Google Scholar
• Sarisaltik Yaşin D, Şafak TZ. Evaluation of biorelevant dissolution media simulating fasted and fed states. FABAD J Pharm Sci. 2018;43:307–322.
   Google Scholar
• Kleberg K, Jacobsen J, Müllertz A. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies. J Pharm Pharmacol. 2010;62(11):1656–1668.
   PubMed Web of Science ®Google Scholar
• Armand M, Borel P, Ythier P, et al. Effects of droplet size, triacylglycerol composition, and calcium on the hydrolysis of complex emulsions by pancreatic lipase: an in vitro study. J Nutrit Biochem. 1992;3(7):333–341.
   Web of Science ®Google Scholar
• Kanicky JR, Shah DO. Effect of degree, type, and position of unsaturation on the pKa of long-chain fatty acids. J Colloid Interface Sci. 2002;256(1):201–207.
   PubMed Web of Science ®Google Scholar
• Patton JS, Carey MC. Watching fat digestion the formation of visible product phases by pancreatic lipase is described. Am Assoc Adv Sci. 1979;204(4389):145–148.
   Google Scholar
• Staggers JE, Hernell O, Stafford RJ, et al. Physical-chemical behavior of dietary and biliary lipids during ıntestinal lipid systems patterned after aqueous duodenal contents of healthy adult human beings? Digestion and absorption. 1. Phase behavior and aggregation states of model. Biochemistry. 1990;29(8):2028–2040.
   PubMed Web of Science ®Google Scholar
• Yeom DW, Chae BR, Son HY, et al. Enhanced oral bioavailability of valsartan using a polymer-based supersaturable selfmicroemulsifying drug delivery system. Int J Nanomed. 2017;12:3533–3545.
   PubMed Web of Science ®Google Scholar
• Shin DJ, Chae BR, Goo YT, et al. Improved dissolution and oral bioavailability of valsartan using a solidified supersaturable self-microemulsifying drug delivery system containing gelucire® 44/14. Pharmaceutics. 2019;11(2):19–58.
   PubMed Web of Science ®Google Scholar
• DIOVAN®(Valsartan) Tablets [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021283s033lbl.pdf
   Google Scholar